Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -36.54% is 45% above its 1-year average of -65.96%, near the high end of its 1-year range (-109.60%–-26.22%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.61% above its 12-month average of -51.19%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -36.54%.
RETURN ON INVESTED CAPITAL (ROIC)
-36.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.61%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.40%
median of 552 covered companies
CURRENT VS SECTOR MEDIAN
-16.40%
vs the sector median at left
Carlsmed, Inc.
Market Cap
$411.99M
Return on Invested Capital (ROIC)
-36.54%
TTM Avg
-51.19%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$410.91M
Return on Invested Capital (ROIC)
-46.16%
TTM Avg
-62.80%
3Y Avg
-62.80%
5Y Avg
-62.80%
Market Cap
$413.68M
Return on Invested Capital (ROIC)
-19.13%
TTM Avg
-11.02%
3Y Avg
-12.07%
5Y Avg
-13.96%
Market Cap
$410.20M
Return on Invested Capital (ROIC)
-25.26%
TTM Avg
-29.12%
3Y Avg
-26.65%
5Y Avg
-26.65%
Market Cap
$408.14M
Return on Invested Capital (ROIC)
-89.93%
TTM Avg
-54.36%
3Y Avg
-39.52%
5Y Avg
-23.86%
Market Cap
$428.93M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
Market Cap
$392.24M
Return on Invested Capital (ROIC)
-54.07%
TTM Avg
-33.14%
3Y Avg
-21.50%
5Y Avg
-27.82%
Market Cap
$431.90M
Return on Invested Capital (ROIC)
-40.25%
TTM Avg
-30.86%
3Y Avg
-64.07%
5Y Avg
-59.14%
Market Cap
$387.44M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-52.27%
3Y Avg
-73.46%
5Y Avg
-73.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $411.99M | -36.54% | -51.19% | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $410.91M | -46.16% | -62.80% | -62.80% | -62.80% |
| Myriad Genetics, Inc. (MYGN)vs › | $413.68M | -19.13% | -11.02% | -12.07% | -13.96% |
| Shoulder Innovations, Inc. (SI)vs › | $410.20M | -25.26% | -29.12% | -26.65% | -26.65% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $408.14M | -89.93% | -54.36% | -39.52% | -23.86% |
| Editas Medicine, Inc. (EDIT)vs › | $428.93M | -48.61% | -80.33% | -62.04% | -50.84% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $392.24M | -54.07% | -33.14% | -21.50% | -27.82% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $431.90M | -40.25% | -30.86% | -64.07% | -59.14% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $387.44M | -69.35% | -52.27% | -73.46% | -73.46% |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.36M | -2.86% | -34.72% | -61.44% | -57.77% |
ROIC
-36.5%
ROE
-43.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -36.54% |
| 2026-03-31 | -31.30% |
| 2025-12-31 | -26.22% |
| 2025-09-30 | -52.29% |
| 2025-06-30 | -109.60% |
| 2025-03-31 | -96.63% |
| 2024-12-31 | -109.12% |
